Filter Results:
(1,422)
Show Results For
- All HBS Web
(1,422)
- People (4)
- News (400)
- Research (816)
- Events (2)
- Multimedia (16)
- Faculty Publications (564)
Show Results For
- All HBS Web
(1,422)
- People (4)
- News (400)
- Research (816)
- Events (2)
- Multimedia (16)
- Faculty Publications (564)
- November 2013
- Article
Learning from My Successes and from Others' Failures: Evidence from Minimally Invasive Cardiac Surgery
By: D. KC, B. Staats and F. Gino
Learning from past experience is central to an organization's adaptation and survival. A key dimension of prior experience is whether an outcome was successful or unsuccessful. While empirical studies have investigated the effects of success and failure in... View Details
Keywords: Healthcare; Health Care; Knowledge Work; Attribution Theory; Quality; Success; Medical Specialties; Health Care and Treatment; Failure; Learning; Health Industry
KC, D., B. Staats, and F. Gino. "Learning from My Successes and from Others' Failures: Evidence from Minimally Invasive Cardiac Surgery." Management Science 59, no. 11 (November 2013): 2435–2449.
- January 2018 (Revised May 2019)
- Case
Adeo Health Science: Turning a Product into a Brand
By: Elizabeth A. Keenan and Jill Avery
For decades, American parents were warned to avoid introducing potential allergens to their babies prior to their first birthday. But two influential clinical studies caused the medical establishment to radically reverse its position. Parents were now warned that... View Details
Keywords: Startup; Health Care; Consumer; Consumer Products; Branding; Distribution; Retailing; Go To Market Strategy; Marketing; Marketing Channels; Marketing Communications; Brands and Branding; Marketing Strategy; Entrepreneurship; Health Care and Treatment; Consumer Products Industry; Health Industry; United States; North America
Keenan, Elizabeth A., and Jill Avery. "Adeo Health Science: Turning a Product into a Brand." Harvard Business School Case 518-065, January 2018. (Revised May 2019.)
- 06 Sep 2019
- Blog Post
The Business of Medicine: MD/MBA Students Having an Impact
investigation with market research to evaluate access to cancer biopsy devices in East Africa. With her dual degree, Wagner plans to continue her work in health care delivery and her career in improving access to medicine and... View Details
- August 2003 (Revised August 2006)
- Case
New Sector Alliance (A): An Entry into Health Care?
By: Regina E. Herzlinger, Stacy Smollin Schwartz and Jeffrey Cronin
Describes the structure of the U.S. health care system and presents a study of a nonprofit consulting firm that hopes to enter the health care system. Includes descriptions of hospitals, doctors, insurers, medical technology providers, medical devices, pharmaceuticals,... View Details
Keywords: Health; Health Care and Treatment; Health Disorders; Nonprofit Organizations; Health Industry; United States
Herzlinger, Regina E., Stacy Smollin Schwartz, and Jeffrey Cronin. "New Sector Alliance (A): An Entry into Health Care?" Harvard Business School Case 304-004, August 2003. (Revised August 2006.)
- Article
One Obstacle to Curing Cancer: Patient Data Isn't Shared
By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For... View Details
Keywords: Healthcare; Technological And Scientific Innovation; Cancer Care In The U.S.; Cancer Treatment; Precision Medicine; Personalized Medicine; Data Sharing; Technological Innovation; Analytics and Data Science; Health Disorders; Medical Specialties; Research and Development; Customization and Personalization; Health Industry; United States
Hamermesh, Richard G., and Kathy Giusti. "One Obstacle to Curing Cancer: Patient Data Isn't Shared." Harvard Business Review (website) (November 28, 2016).
- March 2015 (Revised February 2022)
- Supplement
CV Ingenuity (B): Epilogue
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors?
The... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Strategy; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (B): Epilogue." Harvard Business School Supplement 315-087, March 2015. (Revised February 2022.)
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
TikToks, comedy-infused content, immersion in pop culture, and one-for-one donation program, the company is ensuring Julie is an essential part of every woman’s medicine cabinet. “Only 17 states require sex-ed to be medically accurate.... View Details
- Article
Managing Healthcare Costs and Value
By: Robert S. Kaplan, Michael E. Porter and Mark L. Frigo
Rising health care costs are a major global challenge. A number of factors contribute to this trend, including aging populations and medical technology. But an underlying and misunderstood source of health care’s escalating costs has been the inability of health care... View Details
Kaplan, Robert S., Michael E. Porter, and Mark L. Frigo. "Managing Healthcare Costs and Value." Strategic Finance 98, no. 7 (January 2017): 24–33.
- Awards
Seidman Lecturer
By: Leemore S. Dafny
Selected as the 14th Annual Seidman Lecturer by the Department of Health Care Policy at Harvard Medical School. View Details
- 31 Jan 2018
- News
Regi’s ‘Innovating in Health Care’ Case Corner
- 30 Mar 2010
- First Look
First Look: March 30
suggest that the bundle of inputs that angel investors provide have a large and significant impact on the success and survival of start-up ventures. Download the paper: http://www.hbs.edu/research/pdf/10-086.pdf The Economic Crisis and View Details
Keywords: Sean Silverthorne
- October 2006 (Revised January 2008)
- Case
Clinical Change at Intermountain Healthcare
By: Richard M.J. Bohmer and Erika Ferlins
Provides a detailed description of the way in which several improvements and innovations in clinical care were arrived at. Describes individual insights, how these were evaluated and validated, and how they were translated into improved medical practices. The changes... View Details
Keywords: Health Care and Treatment; Innovation and Invention; Business Processes; Performance Improvement; Practice; Health Industry
Bohmer, Richard M.J., and Erika Ferlins. "Clinical Change at Intermountain Healthcare." Harvard Business School Case 607-023, October 2006. (Revised January 2008.)
- Research Summary
Behavioral Hazard and Public Policy
It is well recognized that people overuse low-value medical care due to moral hazard—because copays are lower than costs. Now Professor Schwartzstein has introduced the concept of “behavioral hazard” to explain the opposite: people underuse high-value care because... View Details
- 02 Mar 2018
- News
A salute to the Mayo Clinic's retiring servant-leader
- 06 Jan 2015
- Video
Elaine Goodman - Making A Difference
- August 2001 (Revised August 2012)
- Case
BestDoctors, Inc.
By: Regina E. Herzlinger and Seth Bokser
Upon learning the news of a critical illness, patients and their families are shocked, saddened, fearful, and angry all at once. And just as soon as they catch their collective breath, they all ask the same question—a question that has the potential to infuse hope into... View Details
Regina E. Herzlinger
Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and serve on many established and start-up corporate health care/medical... View Details
- 28 Feb 2013
- News
Q&A: Charlie Rose Talks to Harvard's Michael Porter
- 30 Jul 2014
- Video